企業プロフィール
Eagle Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- EGRX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.59 USD (+465.59%)
終値
最終更新: 2026年8月12日
—
時価総額
株価変動の要因
Current closing-price context is not available for EGRX.
企業概要
事業概要
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products. Its business has historically centered on commercialization of focused injectable or hospital-based medicines.
所在地とセクター分類
Eagle is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and hospital care.
ビジネスモデルの特徴
The company depends on product sales, hospital access, and portfolio management. Investors usually watch revenue, execution, and strategic changes.
バイオ業界での位置付け
Eagle occupies a hospital-specialty niche within pharma. It is more commercial than development-stage biotech and tends to respond to product and portfolio developments.
今後のカタリスト
- Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path. The market cares about recurring demand and margin discipline.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。